Apace KY LLC recalls Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15]…

Recall date

February 9, 2018

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0544-2018

FDA classification

Class II

Brand / firm

Apace KY LLC

Sold / distributed

Nationwide

Why it was recalled

Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478